Live Webcasts


Reducing the Risk of Phase III Failures

Date: June 4, 2015 at 11AM ET

It is well documented that 50 percent of Late Phase clinical trials fail due to efficacy and/or safety reasons. The result is a tremendous financial burden to biopharmaceutical companies, the engagement of tens of thousands of patients participating in clinical studies to no avail, and significant time lost for patients looking for viable treatment options in numerous therapeutic areas.

Register free at: www.appliedclinicaltrialsonline.com/act/PhaseIIIRisk

Sponsored by: PAREXEL


Considerations for Formally Validating Software in Laboratories Supporting of CLIA Genomic Assays

Date: June 3, 2015 at 1PM ET

Learn of important challenges and lessons in the CLIA validation of a large genomic oncology-focused assay from Dr. Vic Weigman, Associate Director of Translational Genomics at EA/Quintiles.  

Register free at: www.appliedclinicaltrialsonline.com/act/genomic2

Sponsored by: Quintiles


Optimize Clinical Trial Results Through Reliable Adherence Measurement

Date: June 9, 2015 at 1PM ET

Learn how adherence-informed clinical trials maximize patients’ exposure to the test drugs, simultaneously maximizing drug response and reducing its variance, and thus increasing statistical power. 

Register free at: www.appliedclinicaltrialsonline.com/act/adherence

Sponsored by: MWV


eSource--Easier than you Think

Date: June 11, 2015 at 11AM ET

This webinar will provide summary results from a comprehensive survey on eSource conducted by Applied Clinical Trials (in collaboration with OmniComm Systems). The presenters will highlight opportunities for adoption in the light of current regulatory guidance, the exciting confluence of eSource and Risk Based Monitoring initiatives, and specific technical approaches for gathering and managing eSource data. 

Register free at: www.appliedclinicaltrialsonline.com/act/esource

 Sponsored by: Omnicomm

Demystifying Genomics for Drug Developers

Date: May 19, 2015 at 1PM ET

With the US federal government now backing a Precision Medicine Initiative, genomics, personalized medicines, bioinformatics, and next-generation sequencing have stepped into the spotlight and become new buzzwords for drug developers. But what do all of these terms mean? In this webinar we will explore genomic applications to precision medicine programs and shed light on how genomics is transforming drug development.

Register free at: www.appliedclinicaltrialsonline.com/act/demystifying

Sponsored by: Quintiles


Double Blind: De-Identification and Data Masking

Recorded on April 28, 2015

The number of clinical trial data sets available for secondary analysis has been growing steadily over the last year. While encouraging, there is a need to also ensure that this data is properly de-identified. This webinar will set expectations about what is needed in a de-identification solution for clinical trial data, and offer a pragmatic look at emerging standards in this area.

Register free at: www.appliedclinicaltrialsonline.com/act/blind 


Change Investigative Site Relationships for the Better

Recorded on February 19, 2015

Un-enrolling sites. Slow study start-up. Patient drop out or non-compliance. All of these issues—and more—have been targeted as contributors to high clinical trials costs. But what else do they have in common? They involve principal investigators and site staff. As concern grows, solutions have emerged to help physician researchers better conduct research. Other solutions are aimed to help sponsors identify issues early at the investigative site, to intervene and influence positively when necessary.

Applied Clinical Trials and Partnerships in Clinical Trials join together to bring a group of experts to discuss the importance of the investigator in clinical trials, and how to select and engage them in a true partnership.

Register free at: http://www.appliedclinicaltrialsonline.com/change


Transforming Clinical Operations with a Fully Integrated eTMF Operating Model

Recorded on January 28, 2015

Hear how life sciences companies are moving to a purpose-built eTMF application to transform clinical operations for greater access, visibility, and control of clinical studies.

Register free at: www.appliedclinicaltrialsonline.com/operating

Adaptive Design in Early-Phase Oncology Trials – Best Practices for Conduct

Recorded on: Wednesday, November 12, 2014

Theorem’s Connie Wierman and Jeff Joseph along with Howard Grossberg, MD, and Dr. Sarina Piha-Paul, come together to discuss best practices for implementing adaptive trial designs in early-phase oncology studies for sites, CROs and sponsors.

Register free at: www.appliedclinicaltrialsonline.com/conduct


Comprehend, PFCDM & Versartis- Turn Data Management Into a Strategic Advantage via Analytics

Recorded on: Tuesday, September 23, 2014

Learn how to turn data management into a strategic advantage via clinical, operational and safety analytics. Destroy your competition via data and technology!

Register Free at: www.appliedclinicaltrialsonline.com/strategic

Sponsored by: Comprehend


Responsible Clinical Trials Data Sharing While Safeguarding Privacy

Recorded on: Tuesday, September 16, 2014

Learn anonymization best practices for sharing clinical trial data.  Learn how you can accelerate your clinical transparency initiatives.  Sign up today.

Register Free at: www.appliedclinicaltrialsonline.com/privacy

Sponsored by: Privacy Analytics


The Paper Chase:  Clinical Outcomes Assessments in Today’s Digital Age

Recorded On: Thursday, May 29, 2014 at 11AM EDT

Want to learn if a bring your own device approach is right for your trial? Join Mark Wade, Director, Patient Focused Solutions, and Richard Wagner, Director, Product Management, at Almac as they shed some light on the controversial BYOD debate.

Register Free at: www.appliedclinicaltrialsonline.com/digitalage

Sponsored by: Almac